Search

Your search keyword '"Choi, Joon-Hyouk"' showing total 149 results
Start Over Author "Choi, Joon-Hyouk"
149 results on '"Choi, Joon-Hyouk"'

1. Noninvasive risk assessment and prediction of cardiac outcomes in patients with congestive heart failure or myocardial infarction

Author

Kim, Jong-Youn, Choi, Jong-Il, Park, Hyung Wook, Hwang, Gyo-Seung, Kim, Dae kyeong, Shin, Seung Yong, Choi, Joon Hyouk, Park, Sang Weon, Lee, Dae-In, Kim, Jun Hyung, Kim, Tae-Hoon, Kim, Jin-Seok, Chun, Kwang Jin, Cha, Tae Joon, Kim, Ju Youn, Park, Young Jun, Park, Seung-Jung, Kim, Juwon, Park, Kyoung-Min, On, Young Keun, Kim, June Soo, Nam, Gi-Byoung, Lee, Young Soo, Kim, Dae Hyeok, Ahn, Minsoo, Shin, Dong-Gu, Kim, Nam-Ho, Namgung, June, Park, Yae Min, and Park, Hyoung-Seob

Published
2024
Full Text
View/download PDF

2. Sex differences in the impact of ventricular-arterial coupling on left ventricular function in patients with hypertension.

Author

Joo, Seung-Jae, Boo, Ki Yung, Lee, Jae-Geun, Choi, Joon-Hyouk, and Kim, Song-Yi

Subjects
GLOBAL longitudinal strain, ARTERIAL diseases, FOURIER transforms, HYPERTENSION, HEART failure
Abstract

Increased arterial stiffness elevates aortic load, which can have adverse impacts on left ventricular (LV) function and contribute to the onset of heart failure. This impact is known to be more pronounced in women. Optimal coordination between ventricular contraction and the arterial system is required to maintain efficient cardiac function. This study aimed to investigate sex differences in the impact of ventricular-arterial coupling (VAC) on LV function in patients with hypertension at rest and after handgrip exercise. Echocardiographic indexes of LV volumes, systolic function, and diastolic function were obtained in the usual way. Effective arterial elastance (EA) and index (EAI) were calculated from stroke volume measured using LV outflow waveform. Effective LV end-systolic elastance (ELV) and index (ELVI) were obtained using the single-beat method. Central aortic pressure waveform was recorded using the applanation tonometry. Characteristic impedance (Zc) of aortic root and reflection magnitude (RM) was calculated after Fourier transformation of both aortic pressure and flow waveforms. Sixty-four patients (31 women and 33 men) with hypertension were enrolled. Women showed higher ELVI (1.33±0.34 vs. 1.10±0.29 mmHg/ml∙m2, P = 0.004) and EAI (1.14±0.25 vs. 0.93±0.26 mmHg/ml∙m2, P = 0.001), but VAC was not different (women: 0.88±0.17 vs. men: 0.85±0.11, P = 0.431). Zc and RM were not different between women and men. After handgrip exercise, an increase in ELVI (P = 0.021) and a decrease in VAC (P = 0.035) were observed specifically in men, with no corresponding changes noted in women. In women, VAC was significantly associated with E' velocity (beta -0.344, P = 0.029) and left ventricular global longitudinal strain (beta 0.470, P = 0.012) after adjustment, but in men, no association was found. Hypertensive women demonstrated greater stiffness in both the left ventricle and arterial systems, along with impaired LV contractile reserve in response to handgrip exercise, as compared to men. The ventricular-arterial mismatch had a notable impact on LV diastolic and systolic dysfunction only in women, but not in men. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia

Author

Lee, Hae-Young, Kim, Seok-Yeon, Choi, Kee-Joon, Yoo, Byung-Su, Cha, Dong-Hun, Jung, Hae Ok, Ryu, Dong-Ryeol, Choi, Joon Hyouk, Lee, Kwang Je, Park, Tae Ho, Oh, Ju Hyeon, Kim, Sang Min, Choi, Ji-Yong, Kim, Kye Hun, Shim, Jaemin, Kim, Woo-Shik, Choi, Si-Wan, Park, Dae-Gyun, Song, Pil-Sang, Hong, Taek-Jong, Rhee, Moo-Yong, Rha, Seung-Woon, and Park, Seung Woo

Published
2017
Full Text
View/download PDF

8. Impact of cardiac rehabilitation on ventricular-arterial coupling and left ventricular function in patients with acute myocardial infarction.

Author

Yoon, Ho-Min, Joo, Seung-Jae, Boo, Ki Young, Lee, Jae-Geun, Choi, Joon-Hyouk, Kim, Song-Yi, and Lee, So Young

Subjects
MYOCARDIAL infarction, GLOBAL longitudinal strain, CARDIAC rehabilitation, SYSTOLIC blood pressure, HEART beat, DIASTOLE (Cardiac cycle), FOURIER transforms, VENTRICULAR ejection fraction
Abstract

To maintain efficient myocardial function, optimal coordination between ventricular contraction and the arterial system is required. Exercise-based cardiac rehabilitation (CR) has been demonstrated to improve left ventricular (LV) function. This study aimed to investigate the impact of CR on ventricular-arterial coupling (VAC) and its components, as well as their associations with changes in LV function in patients with acute myocardial infarction (AMI) and preserved or mildly reduced ejection fraction (EF). Effective arterial elastance (EA) and index (EAI) were calculated from the stroke volume and brachial systolic blood pressure. Effective LV end-systolic elastance (ELV) and index (ELVI) were obtained using the single-beat method. The characteristic impedance (Zc) of the aortic root was calculated after Fourier transformation of both aortic pressure and flow waveforms. Pulse wave separation analysis was performed to obtain the reflection magnitude (RM). An exercise-based, outpatient cardiac rehabilitation (CR) program was administered for up to 6 months. Twenty-nine patients were studied. However, eight patients declined to participate in the CR program and were subsequently classified as the non-CR group. At baseline, E' velocity showed significant associations with EAI (beta -0.393; P = 0.027) and VAC (beta -0.375; P = 0.037). There were also significant associations of LV global longitudinal strain (LV GLS) with EAI (beta 0.467; P = 0.011). Follow-up studies after a minimum of 6 months demonstrated a significant increase in E' velocity (P = 0.035), improved EF (P = 0.010), and LV GLS (P = 0.001), and a decreased EAI (P = 0.025) only in the CR group. Changes in E' velocity were significantly associated with changes in EAI (beta -0.424; P = 0.033). Increased aortic afterload and VA mismatch were associated with a negative impact on both LV diastolic and systolic function. The outpatient CR program effectively decreased aortic afterload and improved LV diastolic and systolic dysfunction in patients with AMI and preserved or mildly reduced EF. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk:A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS-SPAF)

Author

Jung, Moonki, Byeon, Kyeongmin, Kang, Ki-Woon, Lee, Wang-Soo, Kim, Sang Wook, Park, Yae Min, Hwang, You Mi, Lee, Sung Ho, Jin, Eun-Sun, Roh, Seung-Young, Kim, Jin Seok, Ahn, Jinhee, Lee, So-Ryoung, Choi, Eue-Keun, Ahn, Min-Soo, Lee, Eun Mi, Park, Hwan-Cheol, Lee, Ki Hong, Kim, Min, Choi, Joon Hyouk, Ko, Jum Suk, Kim, Jin Bae, Kim, Changsoo, Lip, Gregory Y. H., and Shin, Seung Yong

Subjects
net clinical benefit, ABCD score, non-vitamin K antagonist oral anticoagulant, atrial fibrillation, antithrombotic treatment
Abstract

BackgroundThe balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear in atrial fibrillation (AF) at non-gender CHA2DS2-VASc scores 0–1. A net clinical benefit (NCB) analysis of ATT may guide stroke prevention strategies in AF with non-gender CHA2DS2-VASc scores 0–1.MethodsThis multi-center cohort study evaluated the clinical outcomes of treatment with a single antiplatelet (SAPT), vitamin K antagonist (VKA), and non-VKA oral anticoagulant (NOAC) in non-gender CHA2DS2-VASc score 0–1 and further stratified by biomarker-based ABCD score (Age [≥60 years], B-type natriuretic peptide [BNP] or N-terminal pro-BNP [≥300 pg/mL], creatinine clearance [ResultsWe included 2465 patients (age 56.2 ± 9.5 years; female 27.0%) followed-up for 4.0 ± 2.8 years, of whom 661 (26.8%) were treated with SAPT; 423 (17.2%) with VKA; and 1040 (42.2%) with NOAC. With detailed risk stratification using the ABCD score, NOAC showed a significant positive NCB compared with the other ATTs (SAPT vs. NOAC, NCB 2.01, 95% confidence interval [CI] 0.37–4.66; VKA vs. NOAC, NCB 2.38, 95% CI 0.56–5.40) in ABCD score ≥1. ATT failed to show a positive NCB in patients with truly low stroke risk (ABCD score = 0).ConclusionsIn the Korean AF cohort at non-gender CHA2DS2-VASc scores 0–1, NOAC showed significant NCB advantages over VKA or SAPT with ABCD score ≥1. BackgroundThe balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear in atrial fibrillation (AF) at non-gender CHA2DS2-VASc scores 0–1. A net clinical benefit (NCB) analysis of ATT may guide stroke prevention strategies in AF with non-gender CHA2DS2-VASc scores 0–1.MethodsThis multi-center cohort study evaluated the clinical outcomes of treatment with a single antiplatelet (SAPT), vitamin K antagonist (VKA), and non-VKA oral anticoagulant (NOAC) in non-gender CHA2DS2-VASc score 0–1 and further stratified by biomarker-based ABCD score (Age [≥60 years], B-type natriuretic peptide [BNP] or N-terminal pro-BNP [≥300 pg/mL], creatinine clearance [ResultsWe included 2465 patients (age 56.2 ± 9.5 years; female 27.0%) followed-up for 4.0 ± 2.8 years, of whom 661 (26.8%) were treated with SAPT; 423 (17.2%) with VKA; and 1040 (42.2%) with NOAC. With detailed risk stratification using the ABCD score, NOAC showed a significant positive NCB compared with the other ATTs (SAPT vs. NOAC, NCB 2.01, 95% confidence interval [CI] 0.37–4.66; VKA vs. NOAC, NCB 2.38, 95% CI 0.56–5.40) in ABCD score ≥1. ATT failed to show a positive NCB in patients with truly low stroke risk (ABCD score = 0).ConclusionsIn the Korean AF cohort at non-gender CHA2DS2-VASc scores 0–1, NOAC showed significant NCB advantages over VKA or SAPT with ABCD score ≥1.

Published
2023
Full Text
View/download PDF

11. Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA2DS2-VASc Score 0-1:A Korean Multi-Center Cohort

Author

Jung, Moonki, Byeon, Kyeongmin, Kang, Ki-Woon, Park, Yae Min, Hwang, You Mi, Lee, Sung Ho, Jin, Eun-Sun, Roh, Seung-Young, Kim, Jin Seok, Ahn, Jinhee, Lee, So-Ryoung, Choi, Eue-Keun, Ahn, Min-Soo, Lee, Eun Mi, Park, Hwan-Cheol, Lee, Ki Hong, Kim, Min, Choi, Joon Hyouk, Ko, Jum Suk, Kim, Jin Bae, Kim, Changsoo, Lip, Gregory Y. H., and Shin, Seung Yong

Subjects
Stroke/etiology, ABCD score, General Medicine, risk stratification, Middle Aged, Risk Assessment, Atrial fibrillation, stroke, Cohort Studies, Anticoagulants/therapeutic use, Fibrinolytic Agents, Risk Factors, Creatinine, Natriuretic Peptide, Brain, Humans, Female, Republic of Korea/epidemiology, Atrial Fibrillation/complications, Biomarkers, Retrospective Studies
Abstract

Purpose: Atrial fibrillation (AF) patients with low to intermediate risk, defined as non-gender CHA 2DS 2-VASc score of 0–1, are still at risk of stroke. This study verified the usefulness of ABCD score [age (≥60 years), B-type natriuretic peptide (BNP) or N-ter-minal pro-BNP (≥300 pg/mL), creatinine clearance (2), and dimension of the left atrium (≥45 mm)] for stroke risk stratification in non-gender CHA 2DS 2-VASc score 0–1. Materials and Methods: This multi-center cohort study retrospectively analyzed AF patients with non-gender CHA 2DS 2-VASc score 0–1. The primary endpoint was the incidence of stroke with or without antithrombotic therapy (ATT). An ABCD score was validated. Results: Overall, 2694 patients [56.3±9.5 years; female, 726 (26.9%)] were followed-up for 4.0±2.8 years. The overall stroke rate was 0.84/100 person-years (P-Y), stratified as follows: 0.46/100 P-Y for an ABCD score of 0; 1.02/100 P-Y for an ABCD score ≥1. The ABCD score was superior to non-gender CHA 2DS 2-VASc score in the stroke risk stratification (C-index=0.618, p=0.015; net reclassi-fication improvement=0.576, p=0.040; integrated differential improvement=0.033, p=0.066). ATT was prescribed in 2353 patients (86.5%), and the stroke rate was significantly lower in patients receiving non-vitamin K antagonist oral anticoagulant (NOAC) therapy and an ABCD score ≥1 than in those without ATT (0.44/100 P–Y vs. 1.55/100 P-Y; hazard ratio=0.26, 95% confidence interval 0.11–0.63, p=0.003). Conclusion: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA 2DS 2-VASc score 0–1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA 2DS 2-VASc score 0–1.

Published
2022
Full Text
View/download PDF

12. Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF).

Author

Jung, Moonki, Byeon, Kyeongmin, Kang, Ki‐Woon, Lee, Wang‐Soo, Kim, Sang Wook, Park, Yae Min, Hwang, You Mi, Lee, Sung Ho, Jin, Eun‐Sun, Roh, Seung‐Young, Kim, Jin Seok, Ahn, Jinhee, Lee, So‐Ryoung, Choi, Eue‐Keun, Ahn, Min‐Soo, Lee, Eun Mi, Park, Hwan‐Cheol, Lee, Ki Hong, Kim, Min, and Choi, Joon Hyouk

Subjects
STROKE prevention, HEMORRHAGE risk factors, ANTICOAGULANTS, RISK assessment, RESEARCH funding, ORAL drug administration, FIBRINOLYTIC agents, VITAMIN K, TREATMENT effectiveness, PEPTIDE hormones, DESCRIPTIVE statistics, SURVEYS, LONGITUDINAL method, ATRIAL fibrillation, RESEARCH, STROKE, PLATELET aggregation inhibitors, CONFIDENCE intervals, DATA analysis software, BIOMARKERS, DISEASE risk factors, CHEMICAL inhibitors
Abstract

Background: The balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear in atrial fibrillation (AF) at non‐gender CHA2DS2‐VASc scores 0–1. A net clinical benefit (NCB) analysis of ATT may guide stroke prevention strategies in AF with non‐gender CHA2DS2‐VASc scores 0–1. Methods: This multi‐center cohort study evaluated the clinical outcomes of treatment with a single antiplatelet (SAPT), vitamin K antagonist (VKA), and non‐VKA oral anticoagulant (NOAC) in non‐gender CHA2DS2‐VASc score 0–1 and further stratified by biomarker‐based ABCD score (Age [≥60 years], B‐type natriuretic peptide [BNP] or N‐terminal pro‐BNP [≥300 pg/mL], creatinine clearance [<50 mL/min], and dimension of the left atrium [≥45 mm]). The primary outcome was the NCB of ATT, including composite thrombotic events (ischemic stroke, systemic embolism, and myocardial infarction) and major bleeding events. Results: We included 2465 patients (age 56.2 ± 9.5 years; female 27.0%) followed‐up for 4.0 ± 2.8 years, of whom 661 (26.8%) were treated with SAPT; 423 (17.2%) with VKA; and 1040 (42.2%) with NOAC. With detailed risk stratification using the ABCD score, NOAC showed a significant positive NCB compared with the other ATTs (SAPT vs. NOAC, NCB 2.01, 95% confidence interval [CI] 0.37–4.66; VKA vs. NOAC, NCB 2.38, 95% CI 0.56–5.40) in ABCD score ≥1. ATT failed to show a positive NCB in patients with truly low stroke risk (ABCD score = 0). Conclusions: In the Korean AF cohort at non‐gender CHA2DS2‐VASc scores 0–1, NOAC showed significant NCB advantages over VKA or SAPT with ABCD score ≥1. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

13. A successfully treated case of primary purulent pericarditis complicated by cardiac tamponade and pneumopericardium

Author

Beom, Jong Wook, Ko, Yeekyoung, Boo, Ki Yung, Lee, Jae-Geun, Choi, Joon Hyouk, Joo, Seung-Jae, Moon, Ji Hwan, Kim, Su Wan, and Kim, Song-Yi

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Cardiology, lcsh:Medical emergencies. Critical care. Intensive care. First aid, Pericardial fluid, Case Report, Pneumopericardium, lcsh:RC86-88.9, Critical Care and Intensive Care Medicine, Critical Care Nursing, medicine.disease, Pericardial effusion, pericarditis, Surgery, Catheter, Pericarditis, Acute pericarditis, Streptococcus anginosus, Pericardiocentesis, Cardiac tamponade, pericardiocentesis, cardiac tamponade, Medicine, business
Abstract

Acute pericarditis is caused by various factors, but purulent pericarditis is rare. Primary purulent pericarditis in immunocompetent hosts is very rare in the modern antibiotics era. We report a successfully treated case of primary purulent pericarditis complicated with cardiac tamponade and pneumopericardium in an immunocompetent host. A 69-year-old female was referred from another hospital because of pleuritic chest pain with a large amount of pericardial effusion. She was diagnosed with acute pericarditis accompanied by cardiac tamponade. We performed emergency pericardiocentesis, with drainage of 360 ml of bloody pericardial fluid. The culture grew Streptococcus anginosus, confirming the diagnosis of acute purulent pericarditis. We performed pericardiostomy because cardiomegaly and pneumopericardium were aggravated after removal of the pericardial drainage catheter. The patient received antibiotics for a total of 23 days intravenously and was discharged with oral antibiotic therapy. Purulent pericarditis is one of the rare forms of pericarditis and is life-threatening. A multimodality approach is required for proper diagnosis and treatment of this disease.

Published
2021

16. Comparisons of Prehospital Delay and Related Factors Between Acute Ischemic Stroke and Acute Myocardial Infarction

Author

Yoon, Cindy W., primary, Oh, Hoonji, additional, Lee, Juneyoung, additional, Rha, Joung‐Ho, additional, Woo, Seong‐Ill, additional, Lee, Won Kyung, additional, Jung, Han‐Young, additional, Ban, Byeolnim, additional, Kang, Jihoon, additional, Kim, Beom Joon, additional, Kim, Won‐Seok, additional, Yoon, Chang‐Hwan, additional, Lee, Heeyoung, additional, Kim, Seongheon, additional, Kim, Sung Hun, additional, Kang, Eun Kyoung, additional, Her, Ae‐Young, additional, Cha, Jae‐Kwan, additional, Kim, Dae‐Hyun, additional, Kim, Moo‐Hyun, additional, Lee, Jang Hoon, additional, Park, Hun Sik, additional, Kim, Keonyeop, additional, Kim, Rock Bum, additional, Choi, Nack‐Cheon, additional, Hwang, Jinyong, additional, Park, Hyun‐Woong, additional, Park, Ki Soo, additional, Yi, SangHak, additional, Cho, Jae Young, additional, Kim, Nam‐Ho, additional, Choi, Kang‐Ho, additional, Kim, Yongcheol, additional, Kim, Juhan, additional, Han, Jae‐Young, additional, Choi, Jay Chol, additional, Kim, Song‐Yi, additional, Choi, Joon‐Hyouk, additional, Kim, Jei, additional, Jee, Sung Ju, additional, Sohn, Min Kyun, additional, Choi, Si Wan, additional, Shin, Dong‐Ick, additional, Lee, Sang Yeub, additional, Bae, Jang‐Whan, additional, Lee, Kunsei, additional, and Bae, Hee‐Joon, additional

Published
2022
Full Text
View/download PDF

19. Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction.

Author

Lee, Jae-Geun, Joo, Seung-Jae, Kim, Song-Yi, Choi, Joon-Hyouk, Boo, Ki Yung, Hwang, Jin-Yong, Hur, Seung-Ho, and Jeong, Myung Ho

Subjects
ACE inhibitors, ENZYME inhibitors, ANGIOTENSIN-receptor blockers, HYPERTENSION, MYOCARDIAL infarction, RENIN-angiotensin system, TREATMENT effectiveness
Abstract

There has been a concern that angiotensin receptor blockers (ARB) may increase myocardial infarction (MI) in hypertensive patients compared with other classes of anti-hypertensive drugs. Angiotensin-converting enzyme inhibitor (ACEI) is recommended as a first-line inhibitor of renin-angiotensin system (RASI) in patients with acute MI (AMI), but ARB is also frequently used to control blood pressure. This study investigated the association of ARB vs. ACEI with the long-term clinical outcomes in hypertensive patients with AMI. Among patients enrolled in the nationwide AMI database of South Korea, the KAMIR-NIH, 4,827 hypertensive patients, who survived the initial attack and were taking ARB or ACEI at discharge, were selected for this study. ARB therapy was associated with higher incidence of 2-year major adverse cardiac events, cardiac death, all-cause death, MI than ACEI therapy in entire cohort. After propensity score-matching, ARB therapy was still associated with higher incidence of 2-year cardiac death (hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.20–2.14; P = 0.001), all-cause death (HR, 1.81; 95% CI, 1.44–2.28; P < 0.001), and MI (HR, 1.76; 95% CI, 1.25–2.46; P = 0.001) than the ACEI therapy. It was concluded that ARB therapy at discharge in hypertensive patients with AMI was inferior to ACEI therapy with regard to the incidence of CD, all-cause death, and MI at 2-year. These data suggested that ACEI be a more appropriate RASI than ARB to control BP in hypertensive patients with AMI. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

20. Comparison of Factors Associated With Direct Versus Transferred-in Admission to Government-Designated Regional Centers Between Acute Ischemic Stroke and Myocardial Infarction in Korea

Author

Kim, Dae-Hyun, primary, Moon, Seok-Joo, additional, Lee, Juneyoung, additional, Cha, Jae-Kwan, additional, Kim, Moo Hyun, additional, Park, Jong-Sung, additional, Ban, Byeolnim, additional, Kang, Jihoon, additional, Kim, Beom Joon, additional, Kim, Won-Seok, additional, Yoon, Chang-Hwan, additional, Lee, Heeyoung, additional, Kim, Seongheon, additional, Kang, Eun Kyoung, additional, Her, Ae-Young, additional, Yoon, Cindy W, additional, Rha, Joung-Ho, additional, Woo, Seong-Ill, additional, Lee, Won Kyung, additional, Jung, Han-Young, additional, Lee, Jang Hoon, additional, Park, Hun Sik, additional, Hwang, Yang-Ha, additional, Kim, Keonyeop, additional, Kim, Rock Bum, additional, Choi, Nack-Cheon, additional, Hwang, Jinyong, additional, Park, Hyun-Woong, additional, Park, Ki Soo, additional, Yi, SangHak, additional, Cho, Jae Young, additional, Kim, Nam-Ho, additional, Choi, Kang-Ho, additional, Kim, Juhan, additional, Han, Jae-Young, additional, Choi, Jay Chol, additional, Kim, Song-Yi, additional, Choi, Joon-Hyouk, additional, Kim, Jei, additional, Sohn, Min Kyun, additional, Choi, Si Wan, additional, Shin, Dong-Ick, additional, Lee, Sang Yeub, additional, Bae, Jang-Whan, additional, Lee, Kun Sei, additional, and Bae, Hee-Joon, additional

Published
2022
Full Text
View/download PDF

28. Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers

Author

Kim, Rock Bum, primary, Hwang, Jin Yong, additional, Park, Hyun Woong, additional, Her, Ae-Young, additional, Lee, Jang Hoon, additional, Kim, Moo Hyun, additional, Yoon, Chang Hwan, additional, Cho, Jae Young, additional, Woo, Sung-Il, additional, Kim, Yongcheol, additional, Han, Jae-Young, additional, Choi, Joon Hyouk, additional, Kim, Song Yi, additional, Choi, Si Wan, additional, Jee, Sung Ju, additional, Lee, Sang Yeub, additional, Won, Ki-Bum, additional, Park, Kyeong-Soo, additional, and Hyun, Dae Woo, additional

Published
2021
Full Text
View/download PDF

29. Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial

Author

Yun, Kyeong Ho, primary, Lee, Seung‐Yul, additional, Cho, Byung Ryul, additional, Jang, Woo Jin, additional, Song, Young Bin, additional, Oh, Ju‐Hyeon, additional, Chun, Woo Jung, additional, Park, Yong Hwan, additional, Im, Eul‐Soon, additional, Jeong, Jin‐Ok, additional, Oh, Seok Kyu, additional, Cho, Deok‐Kyu, additional, Lee, Jong‐Young, additional, Koh, Young‐Youp, additional, Bae, Jang‐Whan, additional, Choi, Jae Woong, additional, Lee, Wang Soo, additional, Yoon, Hyuck Jun, additional, Lee, Seung Uk, additional, Cho, Jang Hyun, additional, Choi, Woong Gil, additional, Rha, Seung‐Woon, additional, Lee, Joo Myung, additional, Park, Taek Kyu, additional, Yang, Jeong Hoon, additional, Choi, Jin‐Ho, additional, Choi, Seung‐Hyuck, additional, Lee, Sang Hoon, additional, Gwon, Hyeon‐Cheol, additional, Hahn, Joo‐Yong, additional, Kim, Dong‐Bin, additional, Cho, Sang Cheol, additional, Hwang, Sun‐Ho, additional, Jeon, Dong Woon, additional, Ryu, Jae Kean, additional, Kim, Moo‐Hyun, additional, Chae, In‐Ho, additional, Kim, Sang‐Hyun, additional, Kim, Hack‐Lyoung, additional, Jin, Dong Kyu, additional, Suh, Il Woo, additional, Park, Jong Seon, additional, Shin, Eun‐Seok, additional, Kim, Shin‐Jae, additional, Cheong, Sang‐Sig, additional, Ho, Kyeong, additional, Lee, Sung Yun, additional, Chae, Jei Keon, additional, Yang, Yong Mo, additional, and Choi, Joon‐Hyouk, additional

Published
2021
Full Text
View/download PDF

30. Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers

Author

Kim, Rock Bum, primary, Hwang, Jin Yong, additional, Park, Hyun-Woong, additional, Her, Ae-Young, additional, Lee, Jang-Hoon, additional, Kim, Moo Hyun, additional, Yoon, Chang Hwan, additional, Cho, Jae Young, additional, Woo, Sung-Il, additional, Kim, Yongcheol, additional, Han, Jae-Young, additional, Choi, Joon Hyouk, additional, Kim, Song Yi, additional, Choi, Si-Wan, additional, Jee, Sung Ju, additional, Lee, Sang Yeub, additional, Won, Ki-Bum, additional, Park, Kyeong-Soo, additional, and Hyun, Dae Woo, additional

Published
2020
Full Text
View/download PDF

32. Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction

Author

Joo, Seung-Jae, primary, Kim, Song-Yi, additional, Choi, Joon-Hyouk, additional, Park, Hyeung Keun, additional, Beom, Jong Wook, additional, Lee, Jae-Geun, additional, Chae, Shung Chull, additional, Kim, Hyo-Soo, additional, Kim, Young Jo, additional, Cho, Myeong Chan, additional, Kim, Chong Jin, additional, Rha, Seung-Woon, additional, Yoon, Junghan, additional, and Jeong, Myung Ho, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results